Takehiko Yokobori - Search Results

Year	Number of Results
2007	1
2008	1
2009	5
2010	10
2011	11
2012	7
2013	15
2014	14
2015	16
2016	17
2017	33
2018	20
2019	24
2020	31
2021	30
2022	22
2023	19
2024	10

1

Cancer-associated fibroblast spatial heterogeneity and EMILIN1 expression in the tumor microenvironment modulate TGF-β activity and CD8⁺ T-cell infiltration in breast cancer.

Honda CK, Kurozumi S, Fujii T, Pourquier D, Khellaf L, Boissiere F, Horiguchi J, Oyama T, Shirabe K, Colinge J, Yokobori T, Turtoi A. Honda CK, et al. Among authors: yokobori t. Theranostics. 2024 Feb 24;14(5):1873-1885. doi: 10.7150/thno.90627. eCollection 2024. Theranostics. 2024. PMID: 38505604 Free PMC article.

2

Effectiveness of Combination Chemotherapy With Docetaxel, Nedaplatin, and 5-Fluorouracil for Advanced and Recurrent Esophageal Cancer.

Sohda M, Hara K, Kuriyama K, Tateno K, Uchida S, Watanabe T, Shibasaki Y, Saito H, Nakazawa N, Sano A, Sakai M, Yokobori T, Ogawa H, Shirabe K, Saeki H. Sohda M, et al. Among authors: yokobori t. Anticancer Res. 2024 Mar;44(3):1309-1315. doi: 10.21873/anticanres.16926. Anticancer Res. 2024. PMID: 38423646

3

Editorial Comment on: Cancer-Associated Fibroblast-Derived IL-8 Upregulates PD-L1 Expression in Gastric Cancer Through the NF-κB Pathway.

Yokobori T. Yokobori T. Ann Surg Oncol. 2024 May;31(5):2811-2812. doi: 10.1245/s10434-024-15017-1. Epub 2024 Feb 12. Ann Surg Oncol. 2024. PMID: 38347329 No abstract available.

4

Potential of Mac-2-binding protein glycan isomer as a new therapeutic target in pancreatic cancer.

Yamanaka T, Araki K, Yokobori T, Muranushi R, Hoshino K, Hagiwara K, Gantumur D, Ishii N, Tsukagoshi M, Watanabe A, Harimoto N, Masamune A, Uojima H, Mizokami M, Ito K, Shirabe K. Yamanaka T, et al. Among authors: yokobori t. Cancer Sci. 2024 Apr;115(4):1241-1249. doi: 10.1111/cas.16087. Epub 2024 Feb 6. Cancer Sci. 2024. PMID: 38321872 Free PMC article.

5

Efficacy of thoracic endovascular aortic repair for aorto-esophageal fistula due to esophageal cancer: a systematic review and meta-analysis.

Sakai M, Sohda M, Uchida S, Yamaguchi A, Watanabe T, Saito H, Nakazawa N, Kuriyama K, Sano A, Ogawa H, Yokobori T, Nagai K, Shirabe K, Saeki H. Sakai M, et al. Among authors: yokobori t. Esophagus. 2024 Apr;21(2):95-101. doi: 10.1007/s10388-024-01042-2. Epub 2024 Feb 1. Esophagus. 2024. PMID: 38302854 Review.

6

Prognostic value of a modified‑immune scoring system in patients with pathological T4 colorectal cancer.

Dorjkhorloo G, Erkhem-Ochir B, Shiraishi T, Sohda M, Okami H, Yamaguchi A, Shioi I, Komine C, Nakazawa N, Ozawa N, Shibasaki Y, Okada T, Osone K, Sano A, Sakai M, Ogawa H, Yokobori T, Shirabe K, Saeki H. Dorjkhorloo G, et al. Among authors: yokobori t. Oncol Lett. 2024 Jan 17;27(3):104. doi: 10.3892/ol.2024.14237. eCollection 2024 Mar. Oncol Lett. 2024. PMID: 38298428 Free PMC article.

7

Identification of MicroRNAs Associated with Histological Grade in Early-Stage Invasive Breast Cancer.

Kurozumi S, Seki N, Narusawa E, Honda C, Tokuda S, Nakazawa Y, Yokobori T, Katayama A, Mongan NP, Rakha EA, Oyama T, Fujii T, Shirabe K, Horiguchi J. Kurozumi S, et al. Among authors: yokobori t. Int J Mol Sci. 2023 Dec 19;25(1):35. doi: 10.3390/ijms25010035. Int J Mol Sci. 2023. PMID: 38203206 Free PMC article.

8

RNF31 promotes proliferation and invasion of hepatocellular carcinoma via nuclear factor kappaB activation.

Hoshino K, Nakazawa S, Yokobori T, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Araki K, Harimoto N, Tokunaga F, Shirabe K. Hoshino K, et al. Among authors: yokobori t. Sci Rep. 2024 Jan 3;14(1):346. doi: 10.1038/s41598-023-50594-3. Sci Rep. 2024. PMID: 38172174 Free PMC article.

9

Usefulness of the preoperative inflammation-based prognostic score and the ratio of visceral fat area to psoas muscle area on predicting survival for surgically resected adenocarcinoma of the esophagogastric junction.

Uchida S, Sohda M, Tateno K, Watanabe T, Shibasaki Y, Nakazawa N, Kuriyama K, Sano A, Yokobori T, Sakai M, Ogawa H, Shirabe K, Saeki H. Uchida S, et al. Among authors: yokobori t. Esophagus. 2024 Apr;21(2):157-164. doi: 10.1007/s10388-023-01034-8. Epub 2023 Dec 19. Esophagus. 2024. PMID: 38112929

10

Association Between High Expression of Phosphorylated-STMN1 and Mesenchymal Marker Expression and Cancer Stemness in Breast Cancer.

Handa T, Yokobori T, Obayashi S, Fujii T, Shirabe K, Oyama T. Handa T, et al. Among authors: yokobori t. Anticancer Res. 2023 Dec;43(12):5341-5348. doi: 10.21873/anticanres.16737. Anticancer Res. 2023. PMID: 38030185

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

236 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year